Blood-based neurochemical diagnosis of vascular dementia: a pilot study.

  title={Blood-based neurochemical diagnosis of vascular dementia: a pilot study.},
  author={Mirko Bibl and Hermann Esselmann and Brit Mollenhauer and Godehard Weniger and Volker Welge and Michael Liess and Piotr Lewczuk and Markus Otto and J{\"o}rg Bernhard Schulz and Claudia Trenkwalder and Johannes Kornhuber and Jens Wiltfang},
  journal={Journal of neurochemistry},
  volume={103 2},
Blood-based tests for the differential diagnosis of Alzheimer's disease (AD) are under intensive investigation and have shown promising results with regard to Abeta40 and Abeta42 peptide species in incipient AD. Moreover, plasma Abeta40 was suggested as an independent cerebrovascular risk factor candidate. These considerations prompted us to analyse a total of 72 plasma samples in vascular dementias (VAD, n = 15), AD with cerebrovascular disease (AD with CVD, n = 7), AD (n = 15), Parkinson's… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 20 extracted citations

Diagnostic Utility of CSF Tau and Aβ42 in Dementia: A Meta-Analysis

International journal of Alzheimer's disease • 2011
View 8 Excerpts
Highly Influenced

Neurochemical biomarkers in Alzheimer's disease and related disorders.

Therapeutic advances in neurological disorders • 2012
View 5 Excerpts

Plasma amyloid-beta peptides in acute cerebral ischemia: a pilot study.

Journal of clinical laboratory analysis • 2012
View 2 Excerpts

Similar Papers

Loading similar papers…